Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Refractory Migraine
NCT00660192Phase 3Completed
- Sponsor
- Yale University
- Start
- Jan 2008
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in chronic migraine, sponsored by Yale University. Started Jan 2008; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT00660192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660192.